The best of pharmaceutical expertise for the betterment of humankind

Our Mission

To be amongst the top 25 Pharmaceutical companies of India and to achieve this objective, through both organic and inorganic growth.

Our Vision

To be a globally admired Pharmaceutical company for world-class quality and innovation.

Shreya Life Sciences is a state-of-the-art Pharmaceutical Organisation involved in Research, Manufacturing, Marketing, Sales and Distribution of Medicinal Formulations and Products.

Beginning its journey in 1995 in Russia, Shreya Life Sciences started as a pharmaceutical distributing and marketing company. In the course of over two decades, Shreya Life Sciences has pioneered innovations and Achieved milestones in acquiring new companies, commissioning new products as well as expanding its market & contract manufacturing presence w/ reach and operations in Russia.

about img

Core Team

How we Work


Sales, Marketing & Export

Domestic Sales & Marketing is one of the core operations at SHREYA, where in, it has All India Operations spread across the country from North to South and East to West.
Export is another core operation with rapid spread across the continents through aggressive registration of Products and appointment of local distributors at each territory.


Manufacturing and R&D Activities

To maintain full control on the quality and production of the products that Shreya markets, it gets most of its products manufactured in house for which it has two Ultra modern manufacturing bases, one at Aurangabad and another at Roorkee.
Shreya’s R&D specializes in novel formulation development and is based at Aurangabad, Maharashtra.


Business Development, Contract Manufacture & Strategic Alliances

Shreya is open to extend its business operations in unchartered territories and is willing to have business collaborations with over seas buyers. We can do contract manufacture of products either in our brand name or in the buyer’s brand name. Shreya is keen to tie up for any new product’s licensing and new product development as well.

Our Entire Scope of International Exports


- Operations are set up across the country.
- Products are exported in both Prescription & OTC Segments.
- Over 55 products registered & marketed by 160 field force Distribution through six nationally operating distributors.
- Caters to 25000 retail pharmacies (APTEKAS).
- Products distributed through the Public Distribution System of the Russian Govt.


- Shreya Life Sciences began operations in this continent through Ethiopia.
- Current operations include Kenya, Uganda, DRC Congo & Ethiopia.
- Approval to establish plants in Nigeria is currently under process.
- Our Lozenges is under registration in Morocco.


- Partnership with ASNA: A large chain of chemist stores for product marketing with over 3000 retail shops in the country.
- 15 products of Shreya Life Sciences are under registration and expected to start operations soon.


- 24 products under the label of Shreya are registered.
- Contract Manufacturing with SUN Pharma for sale in Myanmar

Papua New Guinea

- Insulin (Recosulin Brand) is exported to Papua New Guinea.

Research & Development

Shreya Life Sciences boasts of a premium research and development facility at the Aurangabad Plant. It has the capability to develop formulations at the lab level, scaling them to commercial batches until validation.

With an extensive experience of Preclinical & Clinical studies by our scientists, we have been pioneering the development of drugs for a very long time.

Proprietary Technologies

A spreading factor that enhances the effect of local anaesthesia, it has wide clinical applications, especially cataract surgery. The source of our Hynidase is ovine compared to bovine originating products in the market, thus being free of TSE/BSE infections.

We have a dedicated Insulin Formulation Facility that formulates both 40 IU & 100 IU insulin. Our insulin products are created in regular, NPH, 30/70 and 50/50 varieties.

We provide in-house formulations of Dextrans and Iron Dextrans, which are manufactured as APIs.

Formulations of Salmon Calcitonins are created in the forms of injections and nasal spray for treating osteoporosis.

Research Projects
Phase III Trial & Study

Novel Buccal Delivery of Insulin formulation was studied in a Phase III Study comparing over the injectable regular insulin. This was a multicentric study on 198 patients from 13 centres across India and the study proved that this formulation is as good as injectable insulin.